For those cases with immunoreactivity above the median score, HuR cytoplasmic expression was significantly correlated with poor outcomes and adverse clinicopathological factors, such as a higher histological grade, an advanced pathological status, the presence of lymph node metastasis, the pattern of invasion, and vascular/perineurial invasion. This evidence concerns the gene ELAVL1 and metastatic malignant neoplasm in the lymph nodes.